Slate Medicines Emerges With $130 Million to Chase PACAP, a Migraine Target Distinct From CGRP
2 months ago
In DealsFunding RoundsInnovationInvestments
Biotech M&A Surpasses $106 Billion in 2026 as Big Pharma Races to Replenish Pipelines Before Patent Cliffs
3 months ago
In DealsFunding RoundsInvestmentsPartnerships
NewLimit Raises $435 Million Series C to Advance Epigenetic Reprogramming Platform Targeting Age-Related Disease
3 months ago
In Clinical TrialsDealsInvestmentsPartnerships
Setrusumab Trial Update Disappoints Investors Despite Continued Clinical Progress
1 year ago
In InvestmentsVenture Capital
aTyr Pharma Added to Russell 2000® and Russell 3000® Indexes, Reflecting Growth and Market Confidence
1 year ago
In Biopharma HighlightsInnovationInvestmentsPeoplePharma Industry Updates
Oncolytics Biotech Highlights Growing Investor Interest as Global Oncology Drug Market Surpasses $900 Billion Forecast
1 year ago
In Biopharma HighlightsClinical TrialsInnovationInvestments
Outsized Funding in Early-Stage Biotech Points to Investor Confidence in Novel AI-Backed Oncology Tools
1 year ago
In AI & DataInvestments
Glycomine raises $115 million to push PMM2-CDG therapy into Phase 2b trial
1 year ago
In InvestmentsPeopleVenture Capital
Big Bets and Strategic Moves Drive Biotech Investment in 2025
1 year ago
In InvestmentsLeadersPartnerships
Eli Lilly’s $27 Billion Investment Highlights Surge in Biotech Funding and Strategic Partnerships
2 years ago
In DealsInvestmentsPeople
Takeda Seals Major $770 Million Drug Design Partnership While Other Biotech Firms Secure Vital Financing
2 years ago
In Funding RoundsInvestmentsPeopleVenture Capital
Big Bets in Biotech: February 2025 Ushers in Megarounds and Strategic Partnerships
2 years ago
In DealsInvestmentsLeadersPeople
Global AI Summit in Paris Sparks Momentum for Ethical, Inclusive AI in Healthcare and Life Sciences
2 years ago
In AI & DataIndustry ConferencesInnovationInvestmentsLeadersPeople
Atalanta Therapeutics Secures $97M Series B to Advance RNAi Treatments for Epilepsy and Huntington’s Disease
2 years ago
In Clinical TrialsInvestmentsPartnershipsResearch UpdatesVenture Capital
North America Leads January Biotech Funding Round with Nearly $2 Billion Raised, Oncology and Obesity Startups Dominate
2 years ago
In Breaking NewsInvestmentsPartnershipsVenture Capital
Survey Reveals Clinicians Feel Ill-Prepared for Sex Differences in Disease Despite Frequent Observations
2 years ago
In Industry ConferencesInvestmentsPeopleTop Stories
Neumora’s Depression Drug Stumbles in Pivotal Phase 3, Stock Plummets Over 80%
2 years ago
In Clinical TrialsInvestmentsResearch UpdatesTop Stories
New Venture Capital Firms Step In to Fuel Clinical Research Amid Biotech Funding Shift
2 years ago
In Funding RoundsInvestmentsPeopleVenture Capital
Cellarity’s AI-Designed Cell Therapy Enters Phase 1 for Solid Tumors, Backed by $250M Series D
2 years ago
In Biopharma HighlightsClinical TrialsInvestmentsVenture Capital
Celosia Therapeutics Raises $16.75M to Advance Gene Therapy for ALS
2 years ago
In BreakthroughsInvestmentsPartnerships
Strand Therapeutics Raises $153M to Advance mRNA Cancer Therapies
2 years ago
In InvestmentsPeopleResearch Updates
AI-Powered Drug Discovery Accelerates Biopharma Innovation and Reduces R&D Costs
2 years ago
In Featured AnalysisInvestmentsPartnershipsResearch UpdatesTechnologyTop Stories
FDA Grants RMAT Designation to ExoGene’s Exosome-Based Gene Therapy for ALS
2 years ago
In FDA ApprovalsInvestmentsPharma Industry Updates